Urology

Reports of high-impact urology studies by medical professionals

Routine urinary tract cancer testing among all patients with microhematuria has low diagnostic yield

1. Evaluation with cystoscopy and CT urography for patients presenting with microhematuria (MH) had a low diagnostic yield for urinary tract cancers. 2. The diagnostic...

Enfortumab vedotin prolongs survival in previously treated advanced urothelial carcinoma

1. Enfortumab vedotin showed improved overall survival when compared to chemotherapy in patients with previously treated advanced urothelial carcinoma. 2. The incidence of serious adverse...

Tamsulosin therapy associated with significant reduction of symptoms of overactive bladder

1. Among men with symptoms of overactive bladder with or without concomitant benign prostatic hyperplasia, tamsulosin therapy significantly reduced the symptoms of overactive bladder. Evidence...

Perioperative anticoagulation post robot-assisted radical prostatectomy not associated with increased high-grade bleeding risk

1. Patients continuing perioperative anticoagulation when undergoing robot-assisted radical prostatectomy did not experience an increased incidence of high-grade bleeding. Evidence Level Rating: 2 (Good) Robot-assisted radical...

Adjuvant radiotherapy may worsen outcomes compared to salvage radiotherapy post radical prostatectomy

1. Adjuvant radiotherapy was found to increase the risk of urinary incontinence and urethral strictures compared to salvage radiotherapy in patients with prostate cancer. 2....

Gastric bypass surgery more effective than medical therapy alone for achieving microalbuminuria remission in...

1. Patients who underwent Roux-en-Y gastric (RYGB) surgery had higher rates of microalbuminuria remission when compared to those who received only medical treatment at...

Relugolix treatment significantly decreases testosterone levels in advanced prostate cancer

1. Relugolix was shown to significantly decrease testosterone levels for a sustained period of time in male patients with advanced prostate cancer. 2. The risk...

Enzalutamide treatment increases median overall survival in non-metastatic prostate cancer

1. Enzalutamide along with androgen-deprivation therapy was shown to significantly increase median overall survival among men with non-metastatic, castration-resistant prostate cancer. 2. Adverse events for...

MRI-targeted biopsies alone may underestimate grade of prostate cancer 

1. In this prospective cohort, MRI-targeted biopsies alone, underestimated the histologic grade of prostate cancer tumors. 2. The combination of MRI targeted biopsy and systematic...

Folic acid and zinc supplementation in men not associated with increased fertility

1. In couples obtaining infertility treatment, folic acid and zinc supplementation in men did not lead to a significant improvement in semen quality or...

All-time hits